Statement Of Cash Flows [Abstract]

Xbrane Biopharma - Filing #689990

Concept 2022-01-01 to
2022-12-31
2021-01-01 to
2021-12-31
Statement of cash flows [abstract]
Cash flows from (used in) operating activities [abstract]
Cash flows from (used in) operations before changes in working capital
163 186 SEK
181 195 SEK
Adjustments for increase (decrease) in trade and other payables
17 829 SEK
22 671 SEK
Cash flows from (used in) financing activities [abstract]
Payments for share issue costs
13 350 SEK
24 231 SEK

Talk to a Data Expert

Have a question? We'll get back to you promptly.